Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	214.1	222.28	269.57	300.61	195.25	148.63
Cash & Short-Term Investments	214.1	222.28	269.57	300.61	195.25	148.63
Cash Growth	0.48%	-17.54%	-10.33%	53.96%	31.37%	46.83%
Accounts Receivable	228.79	194.67	248.37	301.49	379.88	357.93
Other Receivables	6.28	13	9	10.86	16.13	9.67
Receivables	235.06	207.67	257.37	312.34	396.01	367.6
Inventory	825.41	969	1,211	819.95	753.85	481.24
Prepaid Expenses	20.59	42.28	49.82	16.08	11.97	4.13
Total Current Assets	1,295	1,441	1,788	1,449	1,357	1,002
Property, Plant & Equipment	2,125	2,199	2,292	1,964	1,868	1,542
Long-Term Investments	1,026	1,002	994.48	998.25	1,060	543.89
Other Intangible Assets	2.51	3.77	5.56	7.53	1.8	1.29
Long-Term Deferred Tax Assets	60.29	35.55	20.44	20.14	24.48	16.76
Other Long-Term Assets	83.59	80.91	71.27	125.42	69.35	41.24
Total Assets	4,593	4,763	5,172	4,564	4,381	3,147
Accounts Payable	27.21	41.44	104.36	144.33	78.77	97.71
Accrued Expenses	-	57.75	122.22	193.56	143.72	140.91
Short-Term Debt	250	150	500	100	150	-
Current Portion of Leases	3.08	2.91	3.36	2.54	1.32	2.25
Current Income Taxes Payable	6.75	1.82	10.59	49.98	31.05	106.54
Current Unearned Revenue	71.45	124.31	15.91	53.95	73.99	3.66
Other Current Liabilities	101.54	47.06	74.97	69.83	156.34	49.09
Total Current Liabilities	460.02	425.29	831.41	614.18	635.17	400.16
Long-Term Debt	600	700	700	500	600	-
Long-Term Leases	1.95	3.98	4.47	0.72	1.02	0.82
Long-Term Unearned Revenue	7.68	12.74	27	-	-	-
Long-Term Deferred Tax Liabilities	264.74	263.79	258.54	256.22	250.3	247.5
Total Liabilities	1,334	1,406	1,821	1,371	1,486	648.48
Common Stock	775.6	775.6	775.6	775.6	775.6	775.6
Additional Paid-In Capital	334.53	334.53	334.53	334.32	334.32	334.32
Retained Earnings	2,237	2,312	2,296	2,129	1,744	1,385
Comprehensive Income & Other	-70.54	-65.17	-55.48	-46.05	39.76	3.72
Total Common Equity	3,258	3,357	3,350	3,193	2,894	2,498
Minority Interest	-	-	-	0.19	0.19	0.26
Shareholders' Equity	3,258	3,357	3,350	3,193	2,894	2,499
Total Liabilities & Equity	4,593	4,763	5,172	4,564	4,381	3,147
Total Debt	855.02	856.89	1,208	603.26	752.34	3.07
Net Cash (Debt)	-640.92	-634.61	-938.26	-302.65	-557.09	145.55
Net Cash Per Share	-14.32	-11.27	-12.01	-3.86	-7.11	1.86
Filing Date Shares Outstanding	55.65	77.56	77.56	77.56	77.56	77.56
Total Common Shares Outstanding	55.65	77.56	77.56	77.56	77.56	77.56
Working Capital	835.15	1,016	956.37	834.81	721.91	601.44
Book Value Per Share	58.55	43.28	43.20	41.17	37.31	32.21
Tangible Book Value	3,256	3,353	3,345	3,185	2,892	2,497
Tangible Book Value Per Share	58.51	43.23	43.12	41.07	37.29	32.20
Land	-	1,092	1,092	741.4	741.4	741.4
Buildings	-	948.27	936.09	900.62	826.11	674.26
Machinery	-	2,456	2,389	2,296	2,032	1,761
Construction In Progress	-	59.46	48.39	27.85	126.44	112.29

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.